We undertook this study in order to examine the association between bone mineral density (BMD) and a polymorphism at the first of two potential translation initiation codons in the vitamin D receptor (VDR) gene. This polymorphism was detected by restriction fragment length polymorphism analysis, using polymerase chain reaction (PCR) and the restriction endonuclease FokI. The f allele indicates the presence of the FokI site, and the F allele its absence. The FokI genotype was determined in 174 postmenopausal Korean women, aged 43-71 years. The distribution of FokI genotypes in Koreans was found not to differ significantly from those found in Caucasians and Japanese, although it does differ significantly from that found in the black American population. We observed a significant association between the FokI polymorphism and lumbar BMD; P ϭ 0.048, analysis of covariance [ANCOVA], but no association with femoral neck BMD (P ϭ 0.505, ANCOVA). Those with the ff genotype had a 13.3% lower BMD in the lumbar spine than the FF subjects. In addition, a significantly higher prevalence of the ff genotype was observed in osteoporotic compared with osteopenic or normal women (P ϭ 0.036, 2 test). These data suggest that the ff genotype of the VDR gene correlates with decreased BMD in the lumbar spine in postmenopausal Korean women.
Introduction
Bone mineral density (BMD), the major determinant of osteoporotic fracture risk, is known to be under strong genetic determination . Since the initial report of an association of vitamin D receptor (VDR) polymorphism, defined by the restriction endonucleases ApaI, BsmI, and TaqI, with BMD (Morrison et al. 1994) , many subsequent studies of a variety of populations have reached divergent conclusions, with some investigators finding an association between this polymorphism and BMD (Eiseman 1995) , while others have not (Peacock 1995) .
Cloning of the VDR gene revealed two potential translation initiation codons (ATG) in exon 2 (Baker et al. 1988) . A T/C polymorphism (ATGAEACG) was discovered at the first ATG (Saijo et al. 1991) , and has been defined using Fok I restriction endonuclease (Gross et al. 1996) . Individuals who have an ACG codon, indicated by the F allele, instead of the first ATG codon probably initiate from the second ATG codon, and have a VDR protein three amino acids shorter. This structural difference, caused by the two alleles, may affect the function of the VDR protein. In this regard, it has recently been demonstrated that the shorter form of VDR gives an approximately 1.7-fold greater transcriptional activation in transfected HeLa cells than the longer form, which suggests a difference in the biological activity of the two VDR isoforms (Arai et al. 1997) .
During the past 4 years, several studies have examined the association between BMD and a start codon polymorphism of the VDR gene in pre-and postmenopausal women. The initial study by Gross et al. (1996) , conducted in postmenopausal Caucasian Mexican-American women, showed a 12.8% lower lumbar spine BMD in 15 ff homozygous women when compared with 37 FF homozygous women, and also showed an increased bone loss rate from the femoral neck in ff women when compared with FF women, as observed during a 2-year period. Another study, of postmenopausal Italian women, also showed a weak association between the FokI polymorphism and lumbar BMD (P ϭ 0.060), but no association with femoral neck BMD (Gennari et al. 1999) .
Studies of premenopausal women have shown conflicting results. One study (Arai et al. 1997) , conducted in premenopausal Japanese women, reported a 10.7% lower lumbar spine BMD in 16 ff homozygous women than in 30 FF homozygous women. However, another study (Eccleshall et al. 1998) , conducted in premenopausal French women, reported the lack of an association between the FokI genotype and BMD.
In the present study, we examined the relationship of the Fok I polymorphism with BMD, in a group of 174 postmenopausal Korean women.
Subjects and methods

Subjects
A total of 174 unrelated postmenopausal women who had attended the menopause clinic at Seoul National University Hospital between January 1998 and December 1999, because of possible postmenopausal symptoms or for the evaluation of osteoporotic risk, were recruited for this study. All subjects were Korean, and were enrolled in this study after individually giving their informed consent. Women with a history of bone disease other than primary osteoporosis, or those who had used drugs with activity in bone, or drugs that could potentially affect bone metabolism, prior to BMD measurement were excluded from this study.
The age range of the enrolled women was 43-71 years, with a mean (ϮSD) age of 55.1 Ϯ 6.0 years. On the basis of BMD measurements taken in the lumbar spine (L 2 -L 4 ) and femur neck, and according to the World Health Organization criteria (Kanis et al. 1994) , 66 (37.9%) of the 174 subjects displayed osteoporosis, 62 (35.6%) had osteopenia, and 46 (26.4%) were normal. The general characteristics of the subjects are presented in Table 1 .
Bone densitometry BMD was measured in the lumbar spine (L 2 -L 4 ), femoral neck, trochanter, and Ward's triangle, using a Lunar DPX-L dual-energy X-ray absorptiometer (Lunar Radiation, Madison, WI, USA). A BMD measurement was available for all 174 studied women. The in-vivo coefficient of variation was 1.4% for the lumbar spine, 2.1% for the femoral neck, 1.1% for the trochanter, and 2.1% for Ward's triangle.
Biochemical markers of bone turnover
Blood and urine samples were collected in the morning for the measurement of bone turnover markers. Samples obtained after or during the use of any drugs with activity in bone were excluded from the analysis. Measurements of urinary deoxypyridinoline (DPYD), urinary cross-linked N-telopeptide of type I collagen (NTX), and serum osteocalcin were available for 60, 47, and 110 subjects, respectively. Urinary deoxypyridinoline was measured using enzyme-linked immunosorbent assay (ELISA) kits (Metra Biosystems, Mountain View, CA, USA). Urinary NTX was also determined using ELISA kits (Osteomark, Ostex International, Seattle, WA, USA). The values for DPYD and NTX in the urine samples were expressed per mmol of urinary creatinine. The minimum detection limits were 1.1 nmol/mmol creatinine for DPYD and 1nmol/mmol creatinine for NTX, respectively. Intra-and inter-assay variations for DPYD were 4.3% and 4.6%, respectively. For NTX, the corresponding figures were 7.6% and 4.0%. Serum osteocalcin was measured using competitive radio immunoassay (RIA) kits (Techno Genetics, Milan, Italy). The minimum detection limit was 0.1nmol/l. Intra-and inter-assay variations for osteocalcin were 4.0% and 5.1%, respectively.
Genotyping
In all subjects, genomic DNA was extracted from peripheral blood samples, with the Wizard genomic DNA purification kit (Promega, Madison, WI, USA). FokI start codon polymorphisms were determined according to previously described methods (Gross et al. 1996) , with minor modifications. Briefly, the 265-bp fragment of exon 2 was amplified by polymerase chain reaction (PCR), using the primers 5Ј-AGCTGGCCCTGGCACTGACTCTGCTCT-3Ј and 5Ј-ATGGAAACACCTTGCTTCTTCTCCCTC-3Ј. PCR was performed by adding 0.1-0.5µg of DNA to 50 µl of PCR reaction mixture (final concentration, 50mM KCl, 10 mM Tris HCl (pH 8.3), 1.5mM MgCl 2 , 0.01% [w/v] gelatin, 50µM each dNTP, and 0.5 µM of each primer and 1 U of Taq polymerase). The PCR products were digested with FokI restriction endonuclease (New England Biolabs, Beverly, MA, USA) at 37°C for 4h, and then electrophoresed through a 3% agarose gel, containing ethidium bromide. The presence of the restriction site, which generates two fragments, of 196 bp and 69bp, was indicated by f, while its absence, resulting in a single uncut 265-bp fragment, was indicated by F. Subjects were scored as ff homozygotes, Ff heterozygotes, and FF homozygotes according to the digestion pattern.
Statistical analysis
All results are expressed as means Ϯ SD. Statistical analyses were performed using SPSS Ver8.0 (Manugistic, Values are expressed as means Ϯ SD Rockville, MA, USA). Subject characteristics, such as age, years since menopause, weight, and height, in the FokI genotype groups were compared by analysis of variance. BMD and bone turnover markers for these groups were compared by analysis of covariance (ANCOVA). The following covariates were considered for ANCOVA: age, years since menopause, weight, and height. The frequency distributions of genotypes in the osteoporotic, osteopenic, and normal groups were compared using a 2 test. Given an alpha level of 0.05, this study had 90% statistical power to detect BMD differences between homozygous groups, of about 11.3% in the lumbar spine, 11.7% in the femoral neck., 15.9% in Ward's triangle, and 11.2% in the trochanteric region. A P value of less than 0.05 was considered significant for all analyses.
Results
FokI genotyping was performed in a group of 174 unrelated Koreans. The frequencies of the FokI genotypes were 33.3% for FF, 50.6% for Ff, and 16.1% for ff. The genotype distribution was in Hardy-Weinberg equilibrium (given the expected frequencies of the FF, Ff, and ff genotypes of 34.5%, 48.3%, and 17.2% respectively). There were no significant differences between the FokI genotype groups for age, years since menopause, height, or weight (Table 1) .
As shown in Table 2 , the BMD analysis after adjustments for potential confounding factors, such as age, years since menopause, height, and weight, revealed a significant association between lumbar spine BMD and the FokI genotype (P ϭ 0.048, ANCOVA). Individuals with the ff genotype had a 13.3% lower BMD in the lumbar spine than those with the FF genotype (P ϭ 0.022). The analysis of Zscore values, instead of adjusted BMD values, also showed a significant association between the FokI genotype and BMD in the lumbar spine (P ϭ 0.042, ANCOVA). Additionally, the trochanter BMD, analyzed by Z-score, showed a weak association with the FokI genotype (P ϭ 0.080, ANCOVA). However, no significant association was observed between the FokI genotype and BMD in the femur neck or Ward's triangle. There were no differences between the genotype groups in terms of measurements of serum osteocalcin, urinary DPYD, or urinary NTX.
Genotype determinants for osteoporotic, osteopenic, and normal groups are summarized in Table 3 . We observed a significant three-fold increased prevalence of the ff genotype in osteoporotic women compared with normal women (P ϭ 0.036, 2 test).
Discussion
The distribution of the FokI genotypes in the Korean population is very similar to what was previously described in Mexican-American (Gross et al. 1996) , Japanese (Arai et al. 1997) , white North American (Harris et al. 1997) , French (Eccleshall et al. 1998) , and Swiss (Ferrari et al. 1998b) populations. However, it was significantly different from that described in a black North American population (Harris et al. 1997) .
A previous report on the relationship between VDR polymorphism, defined by restriction endonuclease BsmI, and BMD in a Korean population failed to show a significant association (Lim et al. 1995) . In contrast, the present study showed a significant association between the FokI polymorphism and lumbar spine BMD in postmenopausal Korean women. In the Korean population, ff homozygous women demonstrated a 13.3% lower lumbar spine BMD than FF homozygous women. These results are consistent with an initial report on postmenopausal Caucasian Mexican-American women, which showed a 12.8% lower lumbar spine BMD in 15 ff homozygous women than in 37 FF homozygous women (Gross et al. 1996) . Moreover, our results are also in accord with a previous study in postmenopausal Italian women, which demonstrated a weak association between the FokI polymorphism and lumbar BMD (P ϭ 0.06) but no association with femoral neck BMD (Gennari et al. 1999) .
Our findings that BMD in the trochanteric region, but not in the femoral neck, also showed a weak association with the FokI genotype, suggest that the effect of the FokI genotype on BMD may be more evident in trabecular bone than in cortical bone. As noted previously , a heritable effect on peak bone mass may be more important in the lumbar spine, whereas the heritable effect in the femoral neck may be more influenced by environmental factors, such as calcium intake or vitamin D status.
A recent study reported that the effect of the FokI genotype on lumbar spine BMD was more pronounced during the first 5 years of menopause (Gennari et al. 1999 ). This suggests that the BMD differences among the FokI VDR genotypes could be blunted over time, as occurs with BsmI VDR gene polymorphisms (Riggs et al. 1995; Ferrari et al. 1998a ). Thus, we believe it likely that the BMD differences in the lumbar spine are attributable, at least in part, to the effect of the FokI genotype on peak bone mass. The lower BMD in the lumbar spine in premenopausal Japanese women with the ff genotype (Arai et al. 1997 ) further supports this hypothesis. However, other studies of premenopausal women have failed to show an association between the FokI genotype and lumbar spine BMD, in the French (Eccleshall et al. 1998 ) and white American populations (Harris et al. 1997) . In particular, the latter study showed a significantly lower BMD in the femoral neck, not in the lumbar spine, in ff subjects than in FF or Ff subjects (Harris et al. 1997) .
These conflicting results regarding the relationship of the FokI polymorphism with BMD, as mentioned above, may be partly due to ethnic origin or environmental factors, such as dietary calcium intake (Ferrari et al. 1998b ). Thus, further studies of various ethnic groups are required to elucidate the role of the FokI polymorphism in BMD. In conclusion, we observed a significant association between FokI genotype and BMD in the lumbar spine in postmenopausal Korean women, a finding which is consistent with the findings reported in postmenopausal Caucasian women (Gross et al. 1996) and in premenopausal Japanese women (Arai et al. 1997) .
